coronary syndrome (non-ST-elevation myocardial infarction, NSTEMI). Angiography showed severe three-vessel disease with occlusion of a saphenous vein graft (SVG) to the first diagonal branch but patents grafts to left artery descendent (LIMA) and SVG to the right coronary artery. No coronary intervention was performed and the patient was treated medically (aspirin and ticagrelor) and discharged home after 6 days. Three months later, the patient again was admitted to the hospital with acute coronary syndrome (NSTEMI) and developing cardiogenic shock. Angiography now showed an extensive flow limiting dissection of his LIMA graft with the dissection starting at the ostium of the LIMA. After implantation of an Impella 2.5, percutaneous coronary intervention (PCI) of the graft was performed under guidance by optical coherence tomography (OCT) leading to implantation of a drugeluting stent into the ostium of the LIMA and repeated balloon dilatations of the medial and distal parts of the graft. Antegrade flow was established and the patient's condition improved so that the Impella was removed in the cath lab. After an uneventful course, the patient was discharged home after 6 days. Elective repeat angiography after 8 weeks showed an excellent functional result without persisting signs of LIMA dissection or stenosis.
Introduction
The left internal mammary artery (LIMA) has become the conduit of choice for bypass of the left anterior descending coronary artery because of its superior patency rates especially in comparison to saphenous vein grafts (SVGs). 1 Acute dissection of the LIMA graft is a rare but potentially life-threatening condition that requires immediate and consequent diagnosis and treatment.
Timeline

Case presentation
A 58-year-old man with known history of coronary artery disease was admitted to the emergency department on 14 May 2018 due to acute coronary syndrome. He had previous bypass surgery in 2003 with grafting of the left anterior descending artery (LAD) using the LIMA and two SVGs to right coronary artery (RCA) and the first diagonal branch (RD), respectively. On 12 lead electrocardiogram, there were no relevant pathologies, but serial laboratory testing found a significant rise of cardiac troponin I indicating non-ST-elevation myocardial infarction (high-sensitive Troponin I (hsTnT I): 263 pg/mL; normal range: <26 pg/mL). Medical treatment was initiated with fondaparinux 2.5 mg o.d. subcutaneously and the patient continued to take aspirin. Additionally, ticagrelor was started on 15 May 2018 (180 mg loading dose). Coronary angiography was performed via left radial artery on 15 May 2018 (5-Fr diagnostic catheters; JR4, JL4, AL1 for SVC, BC for LIMA) and revealed a chronic occlusion of the mid LAD as well as of the proximal RCA with no significant lesion of the left circumflex artery. The LIMA graft as well as the SVG to RCA were found to be patent, whereas the SVG to RD was found occluded (Figure 1 ). According to risk-benefit evaluation and as the patient reported that his chest pain had resolved for several hours, no coronary intervention was performed. Transthoracic echocardiography showed mildly reduced left ventricular (LV)-ejection fraction (EF) (52%) with hypokinesia of the anterior and septal walls. The patient was treated at the chest pain unit for 48 h and finally discharged home on 22 May 2018 after an uneventful hospital stay.
On 18 August 2018, the patient was again admitted to the emergency department due to reoccurrence of unstable angina and progressive dyspnoea (blood pressure 129/79 mmHg, heart rate 88/min). Electrocardiogram was found normal, but there was a significant elevated troponin I on admission (hsTnT I: 82 pg/mL; normal range: <26 pg/mL) so that the patient was sent to the cath lab on the same day. Coronary angiography performed via the right femoral artery now showed an extensive dissection of the LIMA leading to impaired blood flow (TIMI I) (for video files see Supplement) . During angiography, a slowly but progressive decline of blood pressure could be observed (RR 98/66, heart rate 94/min), while the patient reported worsening of his dyspnoea. Left ventricular angiography showed akinesia of the anterior and septal walls with a significantly impaired LV-EF (calculated to be 45%) ( Figure 2 ). An Impella 2.5 (Abiomed Europe GmbH, Germany) was inserted via the left femoral artery and percutaneous coronary intervention (PCI) of the LIMA was done using a 6-Fr IMA guiding catheter (Medtronic Launcher, Medtronic, USA) and an Asahi Sion blue wire (Asahi Intecc Co., Japan). After several balloon inflations with 2.0 and 3.0 mm balloons (Pantera Pro, Biotronik, Germany), an Orsiro-DES 3.5 Â 30 mm (Biotronik, Germany) was implanted into the ostium of the graft (10 atm/20 s). At this stage, blood flow through the LIMA was restored, but there was still a visible stenosis of the medial and distal part of the vessel. OCT analysis (Abbott, USA), showed a proper stent placement with good restoration of the lumen of the proximal LIMA, while dissection could still be seen from the distal end of the implanted stent over a length of approximately 50 mm ( Figure 3 ). Due to some malapposition of the implanted drug-eluting stent (DES) in the proximal part, post-dilatation was performed here with a 4.0 Â 15 mm NC balloon (Pantera Leo, Biotronik, Germany). As blood flow in the LIMA graft had persistently normalized (TIMI III) and both haemodynamics and the patients well-being were stabilized, no further stents were implanted. After stepwise weaning, • There might be a substantial delay (3 months in this case) between the initial damaging event of the LIMA (e.g. angiography) and clinical manifestation of the dissection.
• Percutaneous coronary intervention (PCI) is a safe treatment strategy in the majority of cases, and left ventricular assist devices (e.g. Impella) can be used during PCI in the case of haemodynamic compromise.
. . . . . . . . . . . . . . . . . . . . . . . . . . . the Impella 2.5 was removed in the cath lab. The patient was transferred to intensive care unit for monitoring of vital signs until the next day when he was sent to a normal ward. Transthoracic echocardiogram before discharge showed a normalization of LV function (EF 59%) without regional wall motion abnormalities, and the patient was discharged home on 24 August 2018. Elective angiographic follow-up was performed on 22 October 2018 which showed a patent LIMA graft without signs of stenosis or persistent dissection (Figure 4 ).
Discussion
Dissection of the LIMA is a rare event that can be iatrogenic in the setting of coronary angiography or can occur spontaneously (overview of cases given in Khan et al. 2 ). For spontaneous dissection, a mechanism involving extensive physical movement of the arms in conjunction with the adhesion of the LIMA to the chest wall has been proposed. 3 The case reported here seems noteworthy for several reasons. First, the dissection of the LIMA became clinically overt with . . . . . . . . . . . . . . . . . . . . . a latency of 3 months after selective angiography, which is highly suggestive for a catheter-induced initial damaging event that was initially asymptomatic. Second, PCI of the LIMA graft was performed under haemodynamic support with an Impella pump, which to our knowledge has not been reported before. The left ventricular unloading induced by the Impella device prevented the progression of haemodynamic deterioration and potentially limited infarct size as known from experimental studies. 4, 5 Third, due to the length of the dissection, a DES was only implanted into the ostium of the graft while a long segment of the dissected LIMA was only treated by balloon angioplasty, which turned out to be favourable strategy in the followup angiography after 8 weeks. Additionally, the use of OCT to guide PCI was of special value in the presented case. On the one hand, it allowed the diagnosis of partial malapposition of the implanted stent that could be immediately treated with proper post-dilatation. This seems important as a suboptimal result of DES implantation diagnosed by OCT has been linked to unfavourable clinical outcomes. 6 On the other hand, OCT confirmed the diagnosis of the persisting dissection in the medial segment of the graft that was not covered by the stent but also showed the 'benign' aspect of the dissection without signs of flow limitation or obstruction of the true lumen which prompted the abdication of additional stent implantations that otherwise would have potentially increased risk of later stent thrombosis or in-stent restenosis.
Conclusion
Acute dissection of a LIMA graft is a rare event that may lead to a lifethreatening condition. As seen from our case, there might be a substantial delay between the damaging event (e.g. selective LIMA angiography) and the clinical onset of dissection. In the vast majority of cases, dissection of LIMA can be treated by PCI and the use of Impella may improve the safety of the procedure. In extensive lesions, it seems possible to leave non-flow limiting dissections in order to avoid the late complications of complete stenting of the graft. 
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